Skip to content

Clinical trials

Hyperglycemia trials in Malaysia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperglycemia Country / region: Malaysia Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20121
20191
20221
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Unknown status2
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim1
National University of Malaysia1
Novartis Pharmaceuticals1
Sanofi1
Takeda1
Universiti Putra Malaysia1
Universiti Sains Malaysia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperglycemia7
Diabetes Mellitus, Type 23
Breast Neoplasms1
Cognitive Dysfunction1
Diabetes Mellitus1
Glucose Intolerance1
Hereditary Sensory and Autonomic Neuropathies1
Hyperinsulinism1
Insulin Resistance1
Ischemic Stroke1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.